| Entry |
|
|---|
| Name |
Tioguanine (INN);
Lanvis (TN) |
|---|
| Formula |
C5H5N5S
|
|---|
| Exact mass |
167.0266
|
|---|
| Mol weight |
167.1917
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
|
|---|
| Remark |
| Product (DG00684): | D06109<US> |
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Comment |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Other map |
| map00983 | Drug metabolism - other enzymes |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BB Purine analogues
L01BB03 Tioguanine
D08603 Tioguanine (INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG00684 Tioguanine
D08603 Tioguanine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Pentosyltransferases
HPRT1
D08603 Tioguanine (INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG00684 Tioguanine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C8y C 23.3800 -17.1500
2 C8y C 23.3800 -18.6200
3 C8y C 24.5700 -16.4500
4 N5x N 22.1200 -16.7300
5 N5x N 24.5700 -19.2500
6 N4x N 22.1200 -19.0400
7 N4x N 25.8300 -17.2200
8 C8x C 21.2800 -17.9200
9 C8y C 25.8300 -18.5500
10 S0 S 24.5818 -15.0500
11 N1a N 27.0366 -19.2600
BOND 12
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 5 9 2
9 6 8 1
10 7 9 1
11 3 10 2
12 9 11 1
|
|---|
